In the rapidly evolving landscape of biopharmaceutical development, finding the right Contract Development and Manufacturing Organization...
Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19
Case study: Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19 When...
Antibody-Drug Conjugates (ADC) and their potential therapeutic applications
In the dynamic landscape of therapeutic development, antibody-drug conjugates (ADCs) have emerged as a ground-breaking class of...
A review of the therapeutic use of monoclonal antibodies
Therapeutic monoclonal antibodies (mAbs) have become a dominant product class within the biopharmaceutical market. To date, therapeutic...
Key considerations for biologics CDMO tech transfer
A technology transfer (or CDMO tech transfer) consists in transferring process knowledge from development to manufacturing or between...
What are monoclonal antibodies and their therapeutic applications?
Monoclonal antibodies (mAbs) constitute a significant achievement in pharmacology over the past three decades. Here are some answers to...
From a project management perspective, what does it mean to be a full-service CDMO?
Discover our project management approach as a CDMO. GTP Bioways is an experienced CDMO (contract development and manufacturing...
Is your commercial HCP ELISA assay suitable to secure your bioprocess?
In early stages of biotherapeutic development, generic HCP ELISA are an easy-to-use solution to quantify HCP content in DS and show HCP...